| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/07/1999 | WO1999000423A1 Protein that binds trail |
| 01/07/1999 | WO1999000406A1 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 01/07/1999 | WO1999000404A1 Secreted proteins |
| 01/07/1999 | WO1999000137A2 Induction of an activated myeloid dendritic cell phenotype |
| 01/07/1999 | WO1999000136A1 Control of acidic gut syndrome |
| 01/07/1999 | WO1999000002A2 Cyclosporin-containing microemulsion preconcentrate composition |
| 01/07/1999 | WO1998042321A3 Liquid compositions comprising lamivudine |
| 01/07/1999 | EP0889127A1 Serine/threonine protein kinase (H-SGK2) |
| 01/07/1999 | EP0889126A2 YNL075W/HTXFT19 polypeptide |
| 01/07/1999 | EP0889052A2 Immunoreactive peptides from Epstein-Barr virus |
| 01/07/1999 | EP0888541A1 Cryptic peptides and method for their identification |
| 01/07/1999 | EP0888457A1 Adeno-associated virus vector for boosting immunogenicity of cells |
| 01/07/1999 | EP0888353A1 Novel n-7-heterocyclyl pyrrolo 2,3-d]pyridines and their use |
| 01/07/1999 | EP0888351A1 Pyrimido 5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production |
| 01/07/1999 | EP0888347A1 Pharmaceutically useful compounds |
| 01/07/1999 | EP0888337A1 Piperidone tachykinin antagonists |
| 01/07/1999 | EP0888336A1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 01/07/1999 | EP0888335A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases |
| 01/07/1999 | EP0888327A1 Benzopyran derivatives having leukotriene-antagonistic action |
| 01/07/1999 | EP0888307A1 1,3,5-trisubstituted indazole derivatives with an anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating action |
| 01/07/1999 | EP0888303A1 Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains |
| 01/07/1999 | EP0888298A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/07/1999 | EP0888122A1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 01/07/1999 | EP0888120A1 Hla binding peptides and their uses |
| 01/07/1999 | EP0758340B1 Process for the preparation of 4-amino-delta 4-3-ketosteroids via 4-nitro-delta 4-3-ketosteroids |
| 01/07/1999 | DE19728436A1 Niedrigdosierte 15-Desoxyspergualin-Präparate Low-dose 15-deoxyspergualin preparations |
| 01/07/1999 | CA2665707A1 Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum |
| 01/07/1999 | CA2313015A1 Cyclosporin-containing microemulsion preconcentrate composition |
| 01/07/1999 | CA2295229A1 Induction of an activated myeloid dendritic cell phenotype |
| 01/07/1999 | CA2294904A1 Control of acidic gut syndrome |
| 01/07/1999 | CA2294704A1 Protein that binds trail |
| 01/06/1999 | CN1204315A New phenylamidine derivatives process for preparing the same and their use as medicaments |
| 01/06/1999 | CN1204261A Pharmaceutical compositions of macrolides or cyclosporine with polyethoxylated saturated hydroxy-fatty acid |
| 01/06/1999 | CN1203948A Promoter of human endoglin gene and its use |
| 01/06/1999 | CN1041524C Oligopeptides derived from C-reactive protein fragments and its medical composition |
| 01/05/1999 | US5856463 PSKH-1 ribozymes |
| 01/05/1999 | US5856364 Mixture of pyruvate salt, antioxidant and fatty acid |
| 01/05/1999 | US5856354 Tachykinin antagonists |
| 01/05/1999 | US5856330 Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
| 01/05/1999 | US5856325 Reducing inflammation by inhibiting pla2 in a mammal |
| 01/05/1999 | US5856323 Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
| 01/05/1999 | US5856297 Human C3b/C4b receptor (CR1) |
| 01/05/1999 | US5856296 DNA encoding interleukin-4 receptors |
| 01/05/1999 | US5856187 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 01/05/1999 | US5856169 Isolated nucleic acid |
| 01/05/1999 | US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase |
| 01/05/1999 | US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/05/1999 | US5856129 Hydridized detector |
| 01/05/1999 | US5855912 Pharmaceutical compositions for piperidinalkanol compounds |
| 01/05/1999 | US5855901 Compositions useful for stimulating an immune response to an antigen |
| 01/05/1999 | US5855895 Polyphosphazene polyelectrolyte immunoadjuvants |
| 01/05/1999 | CA2132826C Use of borate-polyol complexes in ophthalmic compositions |
| 01/05/1999 | CA2078373C Peptides for the production of preparations for the diagnosis and therapy of systemic lupus |
| 01/02/1999 | CA2221861A1 Ynl075w/htxft19 |
| 01/01/1999 | CA2235785A1 Serine/threonine protein kinase (h-sgk2) |
| 12/30/1998 | WO1998059065A1 Novel method of dna transfer into cells |
| 12/30/1998 | WO1998059063A2 Bovine adenovirus type 3 genome |
| 12/30/1998 | WO1998058945A1 Compounds encoding the protective m-like protein of streptococcus equi and assays therefor |
| 12/30/1998 | WO1998058938A1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
| 12/30/1998 | WO1998058926A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors |
| 12/30/1998 | WO1998058678A1 Anti-cd40l immunotoxins for the treatment of diseases |
| 12/30/1998 | WO1998058672A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome |
| 12/30/1998 | WO1998058670A1 Methods of immunizing adults using anti-meningococcal vaccine compositions |
| 12/30/1998 | WO1998058669A2 Cd154 blockade therapy for pancreatic islet tissue transplantation |
| 12/30/1998 | WO1998058665A1 Use of proteolytic enzymes for preventing or treating graft rejection |
| 12/30/1998 | WO1998058663A1 Use of proteolytic enzymes for influencing cytokines |
| 12/30/1998 | EP0887416A2 Human AFC1 |
| 12/30/1998 | EP0887415A2 Human RCE1 |
| 12/30/1998 | EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor |
| 12/30/1998 | EP0887406A2 A member of the FRZB family, franzzled |
| 12/30/1998 | EP0886679A1 Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 12/30/1998 | EP0886528A1 Use of coxiella bacteria to treat autoimmune disease |
| 12/30/1998 | EP0886520A1 Caffeine and clemastine for treating respiratory disorders |
| 12/30/1998 | EP0760661B1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 12/30/1998 | EP0705258B1 Azolyl-cyclic amine derivatives with immunomodulatory activity |
| 12/30/1998 | EP0618889B1 Tri-substituted phenyl derivatives and processes for their preparation |
| 12/30/1998 | EP0553244B1 Targeted immunostimulation with bispecific reagents |
| 12/30/1998 | EP0463059B1 Allergenic proteins from ragweed and uses therefor |
| 12/30/1998 | CN1203603A Therapeutic compounds comprised of anti-FC receptor antibodies |
| 12/30/1998 | CN1203602A Acylated enol derivatives of 'alpha'-ketoesters and 'alpha'-ketoamides |
| 12/30/1998 | CN1203590A Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 12/30/1998 | CN1203529A 'Gamma'-RAR antagonist ligand or 'alpha'-RAR agonist ligand as apoptosis inhibitor |
| 12/30/1998 | CN1203528A Use of gamma-RAR-specific agonist ligand to increase apoptosis rate |
| 12/30/1998 | CN1203232A 2-carboxymethyl-5-(5-fluoro cyti midine-1-yl) 1,3-oxythiapentane and its derivatives |
| 12/30/1998 | CN1041417C Sulfur-containing heterocyclic compounds, use and drug containing same |
| 12/30/1998 | CA2594375A1 Bovine adenovirus type 3 genome |
| 12/30/1998 | CA2294468A1 Compounds encoding the protective m-like protein of streptococcus equi and assays therefor |
| 12/30/1998 | CA2294154A1 Cd154 blockade therapy for pancreatic islet tissue transplantation |
| 12/30/1998 | CA2294138A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome |
| 12/29/1998 | US5854412 Chemokine N-terminal deletion mutations |
| 12/29/1998 | US5854404 Antitumor substance extracted from grifola |
| 12/29/1998 | US5854257 Naphthyridinone derivatives |
| 12/29/1998 | US5854239 Diazabicyclic neuokinin antagonists |
| 12/29/1998 | US5854234 Amidino dervatives useful as nitric oxide synthase inhibitors |
| 12/29/1998 | US5854055 Recombinant mycobacteria |
| 12/29/1998 | US5854028 Compositions comprising IL-11 and methods of making and using IL-11 |
| 12/29/1998 | US5853987 Decorin binding protein compositions and methods of use |
| 12/29/1998 | US5853976 Recombinant proteinase from clostridium histolyticum and its use for isolating cells and groups of cells |
| 12/29/1998 | US5853736 Potentiation of immunogenic response |
| 12/29/1998 | US5853623 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |